Impact of total splenectomy on peripheral lymphocytes and their subsets in patients with hypersplenism associated with cirrhotic portal hypertension

[1]  M. Koga,et al.  CD4/CD8 ratio predicts the cellular immune response to acute hepatitis C in HIV-coinfected adults. , 2019, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[2]  Zhanguo Zhang,et al.  Benefits of Splenectomy and Curative Treatments for Patients with Hepatocellular Carcinoma and Portal Hypertension: a Retrospective Study , 2018, Journal of Gastrointestinal Surgery.

[3]  Zong-fang Li,et al.  The Spleen Promotes the Secretion of CCL2 and Supports an M1 Dominant Phenotype in Hepatic Macrophages During Liver Fibrosis , 2018, Cellular Physiology and Biochemistry.

[4]  Xiaoyu Han,et al.  Causes of peripheral cytopenia in hepatitic cirrhosis and portal hypertensive splenomegaly , 2017, Experimental biology and medicine.

[5]  M. Hashizume,et al.  Pancreatic fistula after laparoscopic splenectomy in patients with hypersplenism due to liver cirrhosis: effect of fibrin glue and polyglycolic acid felt on prophylaxis of postoperative complications. , 2016, American journal of surgery.

[6]  W. Lau,et al.  Hypersplenism: History and current status , 2016, Experimental and therapeutic medicine.

[7]  Chao Lu,et al.  Retrospective study , 2016, Medicine.

[8]  J. Fujimoto,et al.  Splenectomy attenuates murine liver fibrosis with hypersplenism stimulating hepatic accumulation of Ly-6C(lo) macrophages. , 2015, Journal of hepatology.

[9]  Tingting Zhang,et al.  Assessment of immune cells and function of the residual spleen after subtotal splenectomy due to splenomegaly in cirrhotic patients , 2014, BMC Immunology.

[10]  Y. Lv,et al.  Clinical Study on the Relationship Between Hematocytopenia and Splenomegaly Caused by Cirrhotic Portal Hypertension , 2014, Cell Biochemistry and Biophysics.

[11]  H. Nishina,et al.  Status and prospects of liver cirrhosis treatment by using bone marrow-derived cells and mesenchymal cells. , 2014, Tissue engineering. Part B, Reviews.

[12]  E. Weledji.  Benefits and risks of splenectomy. , 2014, International journal of surgery.

[13]  A. Scarsbrook,et al.  Improving cytopenia with splenic artery embolization in a patient with paroxysmal nocturnal hemoglobinuria on eculizumab , 2013, International Journal of Hematology.

[14]  A. Golshan,et al.  Frequency of Iron Deficiency Anemia in Girls Studying in Mashhad High Schools , 2013, Iranian journal of pediatric hematology and oncology.

[15]  S. Sankararaman,et al.  Severe gastric variceal bleeding successfully treated by emergency splenic artery embolization , 2013, Pediatrics international : official journal of the Japan Pediatric Society.

[16]  Q. Lu,et al.  Cytopenia and autoimmune diseases: a vicious cycle fueled by mTOR dysregulation in hematopoietic stem cells. , 2013, Journal of autoimmunity.

[17]  R. Bacchetta,et al.  Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome: A Paradigm of Immunodeficiency with Autoimmunity , 2012, Front. Immun..

[18]  H. Kitagawa,et al.  Recent role of Hassab's operation for cirrhotic patients: combination with endoscopic procedure for varices. , 2012, Asian journal of surgery.

[19]  W. Peng,et al.  Total embolization of the main splenic artery as a supplemental treatment modality for hypersplenism. , 2011, World journal of gastroenterology.

[20]  H. Okamoto,et al.  Hemodynamic Effects of Combined Therapy Using Partial Splenic Embolization and Transjugular Retrograde Obliteration for Gastric Varices with Gastrorenal Shunt , 2010, World Journal of Surgery.

[21]  P. Svorcan,et al.  [Splenomegaly and thrombocytopenia in patients with liver cirrhosis]. , 2010, Vojnosanitetski pregled.

[22]  L. Cudillo.  Aplastica Anemia And Viral Hepatitis , 2009, Mediterranean journal of hematology and infectious diseases.

[23]  H. Graffner,et al.  Immunocompetence after incidental splenectomy. , 2009, Scandinavian journal of haematology.

[24]  H. Baba,et al.  [The significance of combined treatment for hepatocellular carcinoma with partial splenic embolization and transcatheter arterial chemoembolization using IA call/lipiodol]. , 2008, Gan to kagaku ryoho. Cancer & chemotherapy.

[25]  L. Eissa,et al.  Thrombopoietin level in patients with chronic liver diseases. , 2008, Annals of hepatology.

[26]  A. Moliterno,et al.  Hypersplenism induced by splenic vein ligation , 2008, American journal of hematology.

[27]  Arturo Pereira,et al.  Oxaliplatin-induced immune hemolytic anemia: a case report and review of the literature. , 2007, Anti-cancer drugs.

[28]  Hye Soo Lee,et al.  [Clinical usefulness of the simple technique to diagnose thrombocytopenia using immature platelet fraction]. , 2007, The Korean journal of laboratory medicine.

[29]  Zong-fang Li,et al.  [cDNA microarray-based screening of differentially expressed genes in macrophages in the spleen of patients with portal hypertension and hypersplenism]. , 2006, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

[30]  V. Bourcier,et al.  Partial splenic embolization in patients with cirrhosis: efficacy, tolerance and long-term outcome in 32 patients , 2005, European journal of gastroenterology & hepatology.

[31]  M. Imamura,et al.  Expressions of molecules associated with hepatocyte growth factor activation after hepatectomy in liver cirrhosis. , 2004, Hepato-gastroenterology.

[32]  K. Mullen,et al.  Prevalence of peripheral blood cytopenias (hypersplenism) in patients with nonalcoholic chronic liver disease , 2000, American Journal of Gastroenterology.

[33]  W. Jelkmann,et al.  Hepatic thrombopoietin mRNA levels in acute and chronic liver failure of childhood , 1999, Hepatology.

[34]  Toshiro Ito,et al.  Changes in Serum Thrombopoietin Levels after Splenectomy , 1998, Acta Haematologica.

[35]  K. Tanikawa,et al.  Changes in platelet kinetics after a partial splenic arterial embolization in cirrhotic patients with hypersplenism , 1995, Hepatology.

[36]  P. Marcellin,et al.  CD4+/CD8+ ratio of liver‐derived lymphocytes is related to viraemia and not to hepatitis C virus genotypes in chronic hepatitis C , 1995, Clinical and experimental immunology.

[37]  V. Yu,et al.  β-Lactam antibiotic-induced leukopenia in severe hepatic dysfunction: Risk factors and implications for dosing in patients with liver disease , 1993 .

[38]  A. Sher,et al.  Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni , 1991, The Journal of experimental medicine.

[39]  E. Brown,et al.  Opsonic requirements for intravascular clearance after splenectomy. , 1981, The New England journal of medicine.

[40]  A. Lunderquist,et al.  Embolization of the spleen for treatment of splenomegaly and hypersplenism in patients with portal hypertension. , 1979, Investigative radiology.

[41]  O. Jonasson,et al.  Partial splenic embolization in the treatment of hypersplenism. , 1979, AJR. American journal of roentgenology.

[42]  L. Witts,et al.  SALMONELLAE AND SHIGELLAE , 1954 .

[43]  Jian-wei Li,et al.  Therapeutic effects of laparoscopic splenectomy and esophagogastric devascularization on liver cirrhosis and portal hypertension in 204 cases. , 2014, Journal of laparoendoscopic & advanced surgical techniques. Part A.

[44]  R. Diasio,et al.  A DPYD variant (Y186C) specific to individuals of African descent in a patient with life-threatening 5-FU toxic effects: potential for an individualized medicine approach. , 2014, Mayo Clinic proceedings.

[45]  Y. Lv,et al.  Effect of surgery treatment on hypersplenism caused by cirrhotic portal hypertension. , 2013, Minerva chirurgica.

[46]  T. Srichaikul,et al.  Hemophagocytic syndrome in Dengue hemorrhagic fever with severe multiorgan complications. , 2008, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[47]  K. Hongo,et al.  A case report and review of the literature , 2006, Journal of Neuro-Oncology.

[48]  F. Gao,et al.  [Study on primary hepatocellular carcinoma associated with hypersplenism treated by partial splenic embolization combined with hepatic arterial chemoembolization]. , 2006, Ai zheng = Aizheng = Chinese journal of cancer.

[49]  É. Lavigne,et al.  [Role of vitamin deficiency in pancytopenia in Djibouti. Findings in a series of 81 consectutive patients]. , 2005, Medecine tropicale : revue du Corps de sante colonial.

[50]  Huang Mingshen.  Clinical quantitative study of therapeutic effect of partial splenic embolization (PSE) on portal vein hemodynamics , 2002 .

[51]  V. Yu,et al.  Beta-Lactam antibiotic-induced leukopenia in severe hepatic dysfunction: risk factors and implications for dosing in patients with liver disease. , 1993, The American journal of medicine.